AzTrials
AzTrials

Primary Dysmenorrhea (PD)NCT07213336

A New Treatment for Primary Dysmenorrhea

A study testing Exercise, massage in people with Primary Dysmenorrhea (PD), run by Halic University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Primary dysmenorrhea (PD) is a chronic health condition that affects primarily young women and interferes with daily activities, causes loss of work productivity, and reduces quality of life. Read more about this study

Who is it for?
Ages 18 to 30 years, women only
Conditions the study is for
Primary Dysmenorrhea (PD)
What is being tested?
Exercise, massage
Could I receive a placebo?
No, everyone receives an active treatment
How many people
44 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Dec 2022to 1 May 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Being a woman between the ages of 18 and 30
  • Having a diagnosis of primary dysmenorrhea
  • Not having given birth
  • Having a regular menstrual cycle (28 ± 7 days)

Who cannot join

  • Having been diagnosed with rheumatic, gastrointestinal, psychiatric, neurological diseases, or other chronic pain syndromes
  • Being on any anti-inflammatory, analgesic, or estrogen/progestin pill (OCP) treatment

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Halic University

    Istanbul

Other trials in Turkey (Türkiye)

About this study

Official title: Effect of Trigger Point Massage and Stretching Exercises on Menstruation Symptoms, Pain Intensity and Quality of Life in Primary Dysmenorrhea

Primary dysmenorrhea (PD) is a chronic health condition that affects primarily young women and interferes with daily activities, causes loss of work productivity, and reduces quality of life. In this controlled study, the effects of trigger point massage and stretching exercises applied to patients diagnosed with primary dysmenorrhea on pain severity (Visual Analog Scale), menstrual symptoms (Menstruation Symptom Scale) and quality of life (SF-36) were investigated. Forty-five women who were followed up with the diagnosis of Primary Dysmenorrhea in the Gynecology and Obstetrics Clinic of a local Hospital. Participants were randomly assigned to exercise, exercise+trigger point, and control groups using a computer-generated randomization list. The "Visual Analog Scale" was used to evaluate the severity of menstrual pain, "Menstruation Symptom Scale" was used to evaluate the severity of menstrual symptoms, and "SF-36" was used to evaluate the quality of life.

Read the detailed description

This controlled experimental study included 45 volunteers diagnosed with primary dysmenorrhea by a gynecologist. Participants were randomly assigned to three groups using the "Research Randomizer" web program. The control group (n=14) received no intervention. The stretching exercise group (n=15) received only stretching exercises; the stretching and trigger point group (n=15) received stretching exercises plus trigger point massage of the quadratus lumborum, rectus abdominus, iliopsoas, and hip adductor muscles, all performed by the same trained physiotherapist.

Study Inclusion Criteria:

  • Being a woman between the ages of 18 and 30,
  • Having a diagnosis of primary dysmenorrhea,
  • Being a nulliparous,
  • Having a regular menstrual cycle (28 ± 7 days). Exclusion Criteria
  • Having rheumatic, gastrointestinal, psychiatric, surgical, or other chronic pain syndromes;
  • Being on any anti-inflammatory, analgesic, or non-convertible progestin pill (OCP) Participants in the control group were not included in the treatment program administered to the other participants for 8 weeks, but continued the NSAID medication prescribed by the doctor who diagnosed dysmenorrhea.

Participants in the stretching group underwent a 45-minute exercise program twice a week, accompanied by a physiotherapist, for 8 weeks. Participants in the stretching exercises and trigger point massage group underwent a 45-minute exercise program twice a week, accompanied by a physiotherapist, for 8 weeks.

Being tested
Exercise, massage
Keywords
Stretching exercises, menstrual pain, primary dysmenorrhea, trigger point massage
Medical subject headings
Dysmenorrhea

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Exercise, massageOther

    trigger point massage and stretching exercise

Study groups in NCT07213336
Study groupRoleWhat they receive
1. groupNo interventionControl group
2.groupExperimentalStretching exercise group
Receives: Other: Exercise, massage
3.groupExperimentaltrigger point massage and stretching exercise group
Receives: Other: Exercise, massage

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. SF-36

    SF-36: This questionnaire has 8 subscales, totaling 36 questions: 10 items on "physical function," 7 items on "role limitations due to physical (4 items) and emotional problems (3 items), 2 items on "pain," 4 items on "vitality," 2 items on "social function," 5 items on "mental health," and 5 items on "general health.

    Measured: The 1st and 3rd Most Painful Days of the Menstrual Cycle

  2. Visual Analog Scale

    Visual Analog Scale: The visual analog scale (VAS) is the most commonly used tool for assessing pain intensity. It is easy to use, provides reproducible results, and can be applied to a variety of practice settings.

    Measured: The 1st and 3rd Most Painful Days of the Menstrual Cycle

  3. Personal Information Form

    Personal Information Form: This form includes personal information.

    Measured: The 1st and 3rd Most Painful Days of the Menstrual Cycle

  4. menstrual symptom scale

    It consists of a 5-point Likert-type scale with a total of 24 items. Individuals are asked to rate their menstruation-related symptoms between 1 (never) and 5 (always). The MBI score is calculated by averaging the total scores of the scale items. A higher mean score indicates an increased severity of menstrual symptoms.

    Measured: The 1st and 3rd Most Painful Days of the Menstrual Cycle

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Oct 2025
  2. Study start1 Dec 2022
  3. Primary completion1 Feb 2023
  4. Study completion1 May 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
44 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07213336
Sponsor's protocol ID
HalicU-FTR-ZİK-01
Status last verified
Oct 2025
First submitted
17 Sep 2025
Last updated
8 Oct 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: I do not want it to be shared without being published in any journal.

Questions about this trial

What is this clinical trial studying?

A study testing Exercise, massage in people with Primary Dysmenorrhea (PD), run by Halic University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Oct 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

SF-36 (time frame: The 1st and 3rd Most Painful Days of the Menstrual Cycle). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Oct 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in